Reuters logo
19 天前
BRIEF-Cardiome's partner SteadyMed submits U.S. new drug application for TREVYENT
2017年7月3日 / 中午12点08分 / 19 天前

BRIEF-Cardiome's partner SteadyMed submits U.S. new drug application for TREVYENT

1 分钟阅读

July 3 (Reuters) - Cardiome Pharma Corp

* Cardiome's partner steadymed submits u.s. New drug application for trevyent® for the treatment of pulmonary arterial hypertension

* Cardiome pharma corp - cardiome expects to file trevyent for european medicines agency and health canada approval by end of 2017. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below